NDC11 45802010401
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 45802-0104-01 | 45802-0104 |
| 45802-0104-1 | 45802-0104 |
| 45802-104-01 | 45802-104 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| olopatadine hydrochloride | OLOPATADINE HYDROCHLORIDE | Padagis Israel Pharmaceuticals Ltd | 126ff6eb-62ae-46f2-ab1e-7ac19346c36b | 2023-09-01 | Warnings, Adverse reactions | 45802-104-01 45802-104 45802010401 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.